The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...

Rates of overweight and obesity have more than doubled in the United States during the last three decades, according to a new analysis. By 2050, it’s anticipated that 213 million adults (age, > 25 ...

A new survey from Health found that many GLP-1 users still face stigma and judgment, even as the drugs become more common and ...

In this article, we exploit the recent, rapid diffusion of the use of GLP-1 drugs among individuals with diabetes to measure the effect of the use of these drugs on mental health, self-rated health, ...

GLP-1 medications like Ozempic and Zepbound are transforming chronic disease and weight management, with perimenopausal women among the most common users. Despite their high use in this group, women ...

The proportion of patients taking a GLP-1 weight-loss drug following bariatric surgery increased substantially in recent years, although the timing of initiation after surgery varied widely, a large ...

Share on Pinterest An increasing number of people without diabetes are using GLP-1 agonist drugs for weight loss only. Image credit: MarkHatfield/Getty Images. The last few years have seen a marked ...

The World Anti-Doping Agency (WADA) said it is now monitoring GLP-1 use among elite athletes, including at the Winter Olympics in Italy. Being ‘monitored’ does not mean a substance is prohibited; ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Women who used a GLP-1 before pregnancy were more likely ...